507486 — Caprolactam Chemicals Income Statement
0.000.00%
Last trade - 00:00- IN₹183.54m
- IN₹269.84m
- IN₹67.40m
Annual income statement for Caprolactam Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 63.1 | 20.7 | 98.4 | 69.6 | 67.4 |
| Cost of Revenue | |||||
| Gross Profit | 63 | 15.4 | 92.3 | 64.7 | 54 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 52.1 | 36.7 | 63.2 | 63.7 | 68 |
| Operating Profit | 11 | -16 | 35.2 | 5.9 | -0.647 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 8.91 | -14.7 | 29.7 | 2.72 | -6.84 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.51 | -12.8 | 25.5 | 1.97 | -7.09 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.51 | -12.8 | 25.5 | 1.97 | -7.09 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.51 | -12.8 | 25.5 | 1.97 | -7.09 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.41 | -2.79 | 5.54 | 0.429 | -1.54 |
| Dividends per Share |